Article
Selective use of vandetanib in the treatment of thyroid cancer
Drug Design, Development and Therapy · 2015 · Fallahi P, Di Bari F, Ferrari SM, Spisni R, Materazzi G, Miccoli P, Benvenga S, Antonelli A
Key facts
| Title | Selective use of vandetanib in the treatment of thyroid cancer |
|---|---|
| First author | Fallahi P, Di Bari F, Ferrari SM, Spisni R, Materazzi G, Miccoli P, Benvenga S, Antonelli A |
| Journal | Drug Design, Development and Therapy |
| Published | Jul 3, 2015 |
| DOI | 10.2147/DDDT.S72495 |
| Devices mentioned | K181380 |
| Product codes mentioned | LXH, MAX |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1